• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双色原位杂交技术显示 FISH 探针。

Visualization of FISH Probes by dual-color chromogenic in situ hybridization.

机构信息

Antibody Development, CMC Contrast, Copenhagen, Denmark.

出版信息

Am J Clin Pathol. 2010 Feb;133(2):205-11. doi: 10.1309/AJCP12MHRTFZJPKW.

DOI:10.1309/AJCP12MHRTFZJPKW
PMID:20093229
Abstract

The overall purpose of the study was to demonstrate applicability of the DAKO dual-color chromogenic in situ hybridization (CISH) assay (DAKO Denmark, Glostrup) with respect to 4 fluorescence in situ hybridization (FISH) probes: MYC (c-MYC), EGFR, ERBB2 (HER2), and TOP2A. The study showed that the dual-color CISH assay can convert Texas red and fluorescein isothiocyanate (FITC) signals into chromogenic signals with an almost complete 1:1 conversion ratio. Agreement studies between the FISH assays for HER2 and TOP2A and the corresponding CISH conversion assays showed 100% concordance (kappa values of 1.0) between the CISH and FISH methods for HER2 and TOP2A status. The correlations of the gene copy number to centromere-17 ratios were similarly high, with a correlation coefficient (r) for HER2 and TOP2A of more than 0.95. Owing to the relatively small number of specimens in this study, it is important that the data are confirmed in a larger study.

摘要

本研究的总体目的是展示 DAKO 双色显色原位杂交(CISH)检测(丹麦 Glostrup 的 DAKO 公司)对于 4 种荧光原位杂交(FISH)探针:MYC(c-MYC)、EGFR、ERBB2(HER2)和 TOP2A 的适用性。研究表明,双色 CISH 检测可以将 Texas 红和异硫氰酸荧光素(FITC)信号转化为显色信号,转化率几乎为 1:1。针对 HER2 和 TOP2A 的 FISH 检测与相应的 CISH 转化检测之间的一致性研究表明,CISH 与 FISH 方法在 HER2 和 TOP2A 状态方面具有 100%的一致性(kappa 值为 1.0)。基因拷贝数与着丝粒 17 比值的相关性也很高,HER2 和 TOP2A 的相关系数(r)超过 0.95。由于本研究中标本数量相对较少,因此在更大的研究中确认这些数据非常重要。

相似文献

1
Visualization of FISH Probes by dual-color chromogenic in situ hybridization.双色原位杂交技术显示 FISH 探针。
Am J Clin Pathol. 2010 Feb;133(2):205-11. doi: 10.1309/AJCP12MHRTFZJPKW.
2
The correlation between dual-color chromogenic in situ hybridization and fluorescence in situ hybridization in assessing HER2 gene amplification in breast cancer.双色显色原位杂交与荧光原位杂交在评估乳腺癌HER2基因扩增中的相关性
Diagn Mol Pathol. 2009 Jun;18(2):96-102. doi: 10.1097/PDM.0b013e31817f5227.
3
Topoisomerase IIalpha gene amplification in gastric carcinomas: correlation with the HER2 gene. An immunohistochemical, immunoblotting, and multicolor fluorescence in situ hybridization study.胃癌中拓扑异构酶IIα基因扩增:与HER2基因的相关性。一项免疫组织化学、免疫印迹及多色荧光原位杂交研究。
Hum Pathol. 2006 Oct;37(10):1333-43. doi: 10.1016/j.humpath.2006.05.008. Epub 2006 Aug 10.
4
Analysis of ERBB2 and TOP2A gene status using fluorescence in situ hybridization versus immunohistochemistry in localized breast cancer.在局部乳腺癌中使用荧光原位杂交与免疫组织化学分析ERBB2和TOP2A基因状态
Neoplasma. 2006;53(5):393-401.
5
The incidence of topoisomerase II-alpha genomic alterations in adenocarcinoma of the breast and their relationship to human epidermal growth factor receptor-2 gene amplification: a fluorescence in situ hybridization study.乳腺癌中拓扑异构酶II-α基因改变的发生率及其与人类表皮生长因子受体-2基因扩增的关系:一项荧光原位杂交研究
Hum Pathol. 2005 Apr;36(4):348-56. doi: 10.1016/j.humpath.2005.01.016.
6
Evaluation of HER2 gene amplification in invasive breast cancer using a dual-color chromogenic in situ hybridization (dual CISH).采用双色显色原位杂交(dual CISH)检测浸润性乳腺癌 HER2 基因扩增。
Pathol Int. 2010 Jul;60(7):510-5. doi: 10.1111/j.1440-1827.2010.02553.x.
7
Dual-colour CISH is a reliable alternative to FISH for assessment of topoisomerase 2-alpha amplification in breast carcinomas.双色 CISH 是 FISH 检测乳腺癌拓扑异构酶 2-α扩增的可靠替代方法。
Breast Cancer Res Treat. 2014 Jan;143(1):81-9. doi: 10.1007/s10549-013-2791-8. Epub 2013 Nov 30.
8
TOP2A and HER2 gene amplification as predictors of response to anthracycline treatment in breast cancer.TOP2A和HER2基因扩增作为乳腺癌蒽环类药物治疗反应的预测指标。
Acta Oncol. 2006;45(5):590-6. doi: 10.1080/02841860500543182.
9
Epidermal growth factor receptor (EGFR) gene copy number detection in non-small-cell lung cancer; a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization.非小细胞肺癌中表皮生长因子受体(EGFR)基因拷贝数检测:荧光原位杂交与显色原位杂交的比较
Histopathology. 2007 Nov;51(5):631-7. doi: 10.1111/j.1365-2559.2007.02854.x.
10
Dual-colour chromogenic in situ hybridization for testing of HER-2 oncogene amplification in archival breast tumours.用于检测存档乳腺肿瘤中HER-2癌基因扩增的双色显色原位杂交技术。
J Pathol. 2006 Sep;210(1):3-9. doi: 10.1002/path.2022.

引用本文的文献

1
Dual color chromogenic in situ hybridization for determination of HER2 status in breast cancer: a large comparative study to current state of the art fluorescence in situ hybridization.用于确定乳腺癌中HER2状态的双色显色原位杂交:与当前先进的荧光原位杂交技术的大型比较研究
BMC Clin Pathol. 2012 Feb 14;12:3. doi: 10.1186/1472-6890-12-3.
2
Hybridization for human epidermal growth factor receptor 2 testing in gastric carcinoma: a comparison of fluorescence in-situ hybridization with a novel fully automated dual-colour silver in-situ hybridization method.人表皮生长因子受体 2 检测在胃癌杂交中的应用:荧光原位杂交与新型全自动双色银原位杂交方法的比较。
Histopathology. 2011 Jul;59(1):8-17. doi: 10.1111/j.1365-2559.2011.03894.x.
3
Determination of HER2 amplification in primary breast cancer using dual-colour chromogenic in situ hybridization is comparable to fluorescence in situ hybridization: a European multicentre study involving 168 specimens.
采用双色显色原位杂交技术检测原发性乳腺癌 HER2 扩增与荧光原位杂交技术相当:一项涉及 168 例标本的欧洲多中心研究。
Histopathology. 2010 Mar;56(4):472-80. doi: 10.1111/j.1365-2559.2010.03503.x.